Pharmacological evaluation and validation for the folkloric use of Oligochaeta ramose in constipation and diarrhea

Crude extract of Oligochaeta ramose and its fractions were studied to rationalize its traditional use in GIT disturbance. In spontaneous contracting jejunum preparation, O. ramose (0.01-1.0 mg/mL) caused a transient spasmogenic effect followed by the spasmolytic effect at higher doses (3.0-10.0 mg/m...

Full description

Bibliographic Details
Main Authors: Musaddique Hussain, Shahid Masood Raza, Khalid Hussain Janbaz
Format: Article
Language:English
Published: Bangladesh Pharmacological Society 2014-12-01
Series:Bangladesh Journal of Pharmacology
Subjects:
Online Access:http://www.banglajol.info/bd/index.php/BJP/article/view/20566
id doaj-415f0f537dd14c2b9e0473215245d2cb
record_format Article
spelling doaj-415f0f537dd14c2b9e0473215245d2cb2020-11-25T02:41:37ZengBangladesh Pharmacological SocietyBangladesh Journal of Pharmacology1991-007X1991-00882014-12-0194617623Pharmacological evaluation and validation for the folkloric use of Oligochaeta ramose in constipation and diarrheaMusaddique HussainShahid Masood RazaKhalid Hussain JanbazCrude extract of Oligochaeta ramose and its fractions were studied to rationalize its traditional use in GIT disturbance. In spontaneous contracting jejunum preparation, O. ramose (0.01-1.0 mg/mL) caused a transient spasmogenic effect followed by the spasmolytic effect at higher doses (3.0-10.0 mg/mL). In atropinized jejunum preparation, O. ramose inhibit the spontaneous and K+ (80 mM)-induced contraction at the similar doses (0.01-1.0 mg/mL), suggesting calcium channel blocking effect. The calcium channel blocking effect was confirmed when pretreatment of tissue with O. ramose produced a dose-dependent shift in Ca+2 dose- response curve to the right, similar to that produced by the verapamil. Activity-directed fractionation revealed that the spasmolytic effect is concentrated in the dichloromethane fraction while, aqueous fraction contains both spasmogenic and spasmolytic constituents. This study validate the presence of both spasmogenic and spasmolytic components mediated through muscarinic receptor activation and calcium channel blockade respectively, which may explain its traditional uses in constipation and diarrhea.http://www.banglajol.info/bd/index.php/BJP/article/view/20566Calcium antagonistConstipationDiarrheaMuscarinic stimulationOligochaeta ramoseSpasmogenicSpasmolytic
collection DOAJ
language English
format Article
sources DOAJ
author Musaddique Hussain
Shahid Masood Raza
Khalid Hussain Janbaz
spellingShingle Musaddique Hussain
Shahid Masood Raza
Khalid Hussain Janbaz
Pharmacological evaluation and validation for the folkloric use of Oligochaeta ramose in constipation and diarrhea
Bangladesh Journal of Pharmacology
Calcium antagonist
Constipation
Diarrhea
Muscarinic stimulation
Oligochaeta ramose
Spasmogenic
Spasmolytic
author_facet Musaddique Hussain
Shahid Masood Raza
Khalid Hussain Janbaz
author_sort Musaddique Hussain
title Pharmacological evaluation and validation for the folkloric use of Oligochaeta ramose in constipation and diarrhea
title_short Pharmacological evaluation and validation for the folkloric use of Oligochaeta ramose in constipation and diarrhea
title_full Pharmacological evaluation and validation for the folkloric use of Oligochaeta ramose in constipation and diarrhea
title_fullStr Pharmacological evaluation and validation for the folkloric use of Oligochaeta ramose in constipation and diarrhea
title_full_unstemmed Pharmacological evaluation and validation for the folkloric use of Oligochaeta ramose in constipation and diarrhea
title_sort pharmacological evaluation and validation for the folkloric use of oligochaeta ramose in constipation and diarrhea
publisher Bangladesh Pharmacological Society
series Bangladesh Journal of Pharmacology
issn 1991-007X
1991-0088
publishDate 2014-12-01
description Crude extract of Oligochaeta ramose and its fractions were studied to rationalize its traditional use in GIT disturbance. In spontaneous contracting jejunum preparation, O. ramose (0.01-1.0 mg/mL) caused a transient spasmogenic effect followed by the spasmolytic effect at higher doses (3.0-10.0 mg/mL). In atropinized jejunum preparation, O. ramose inhibit the spontaneous and K+ (80 mM)-induced contraction at the similar doses (0.01-1.0 mg/mL), suggesting calcium channel blocking effect. The calcium channel blocking effect was confirmed when pretreatment of tissue with O. ramose produced a dose-dependent shift in Ca+2 dose- response curve to the right, similar to that produced by the verapamil. Activity-directed fractionation revealed that the spasmolytic effect is concentrated in the dichloromethane fraction while, aqueous fraction contains both spasmogenic and spasmolytic constituents. This study validate the presence of both spasmogenic and spasmolytic components mediated through muscarinic receptor activation and calcium channel blockade respectively, which may explain its traditional uses in constipation and diarrhea.
topic Calcium antagonist
Constipation
Diarrhea
Muscarinic stimulation
Oligochaeta ramose
Spasmogenic
Spasmolytic
url http://www.banglajol.info/bd/index.php/BJP/article/view/20566
work_keys_str_mv AT musaddiquehussain pharmacologicalevaluationandvalidationforthefolkloricuseofoligochaetaramoseinconstipationanddiarrhea
AT shahidmasoodraza pharmacologicalevaluationandvalidationforthefolkloricuseofoligochaetaramoseinconstipationanddiarrhea
AT khalidhussainjanbaz pharmacologicalevaluationandvalidationforthefolkloricuseofoligochaetaramoseinconstipationanddiarrhea
_version_ 1724777574792429568